CN1785284A - 一种含有何首乌的药物组合物 - Google Patents
一种含有何首乌的药物组合物 Download PDFInfo
- Publication number
- CN1785284A CN1785284A CNA200410093887XA CN200410093887A CN1785284A CN 1785284 A CN1785284 A CN 1785284A CN A200410093887X A CNA200410093887X A CN A200410093887XA CN 200410093887 A CN200410093887 A CN 200410093887A CN 1785284 A CN1785284 A CN 1785284A
- Authority
- CN
- China
- Prior art keywords
- radix
- polygoni multiflori
- extraction
- adds
- radix polygoni
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 45
- 239000003814 drug Substances 0.000 claims abstract description 35
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 34
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 34
- 239000008280 blood Substances 0.000 claims abstract description 22
- 210000004369 blood Anatomy 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 51
- 239000000284 extract Substances 0.000 claims description 42
- 238000000605 extraction Methods 0.000 claims description 26
- 238000002360 preparation method Methods 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 18
- 239000012567 medical material Substances 0.000 claims description 14
- 229920001353 Dextrin Polymers 0.000 claims description 11
- 239000004375 Dextrin Substances 0.000 claims description 11
- 235000019425 dextrin Nutrition 0.000 claims description 11
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 10
- 238000003809 water extraction Methods 0.000 claims description 9
- 239000011347 resin Substances 0.000 claims description 8
- 229920005989 resin Polymers 0.000 claims description 8
- 238000002481 ethanol extraction Methods 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 239000004952 Polyamide Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 229920002647 polyamide Polymers 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000019634 flavors Nutrition 0.000 claims description 2
- HDACQVRGBOVJII-JBDAPHQKSA-N ramipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 HDACQVRGBOVJII-JBDAPHQKSA-N 0.000 claims 2
- 229940077927 altace Drugs 0.000 claims 1
- 238000000247 postprecipitation Methods 0.000 claims 1
- 229960003401 ramipril Drugs 0.000 claims 1
- 240000007164 Salvia officinalis Species 0.000 abstract description 6
- 230000036772 blood pressure Effects 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- 235000005412 red sage Nutrition 0.000 abstract description 2
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 239000002775 capsule Substances 0.000 description 17
- 239000012141 concentrate Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000007788 liquid Substances 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 239000000902 placebo Substances 0.000 description 12
- 229940068196 placebo Drugs 0.000 description 12
- 241001289529 Fallopia multiflora Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 208000004930 Fatty Liver Diseases 0.000 description 9
- 206010019708 Hepatic steatosis Diseases 0.000 description 9
- 208000010706 fatty liver disease Diseases 0.000 description 9
- 231100000240 steatosis hepatitis Toxicity 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 108010007622 LDL Lipoproteins Proteins 0.000 description 6
- 102000007330 LDL Lipoproteins Human genes 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 235000014347 soups Nutrition 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 235000017276 Salvia Nutrition 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 108010010234 HDL Lipoproteins Proteins 0.000 description 3
- 102000015779 HDL Lipoproteins Human genes 0.000 description 3
- 244000131316 Panax pseudoginseng Species 0.000 description 3
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 102000011759 adducin Human genes 0.000 description 2
- 108010076723 adducin Proteins 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 238000005325 percolation Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 2
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241001523579 Ostrea Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 239000009724 Salvia extract Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000002302 brachial artery Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000020 effect on hyperlipemia Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- -1 filter Substances 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 229930189533 tanshinol Natural products 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
血压 | 收缩压 | 舒张压 | |||
服药前 | 服药后 | 服药前 | 服药后 | ||
何首乌胶囊组 | 平均值 | 131.90 | 124.05 | 73.80 | 73.50 |
变化 | -5.95 | -0.41 | |||
T-检验 | 0.01 | 0.85 | |||
安慰剂组 | 平均值 | 121.85 | 119.45 | 71.85 | 71.40 |
变化 | -1.97 | -0.63 | |||
T-检验 | 0.20 | 0.40 |
血脂 | 胆固醇 | 高密度脂蛋白 | |||
服药前 | 服药后 | 服药前 | 服药后 | ||
何首乌胶囊组 | 平均值 | 6.51 | 6.28 | 1.92 | 1.88 |
变化 | -3.65 | -6.40 | |||
T-检验 | 0.09 | 0.70 | |||
安慰剂组 | 平均值 | 6.79 | 6.78 | 1.71 | 1.66 |
变化 | -0.13 | -3.30 | |||
T-检验 | 0.95 | 0.26 |
血脂 | 甘油三酯 | 低密度脂蛋白 | |||
服药前 | 服药后 | 服药前 | 服药后 | ||
何首乌胶囊组 | 平均值 | 4.10 | 3.88 | 1.22 | 1.14 |
变化 | -5.37 | -6.96 |
T-检验 | 0.11 | 0.23 | |||
安慰剂组 | 平均值 | 4.43 | 4.36 | 1.71 | 1.69 |
变化 | -1.54 | -1.39 | |||
T-检验 | 0.54 | 0.77 |
Claims (12)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200410093887XA CN1785284B (zh) | 2004-12-10 | 2004-12-10 | 一种含有何首乌的药物组合物 |
PCT/CN2005/002089 WO2006060951A1 (fr) | 2004-12-10 | 2005-12-05 | Composition pharmaceutique pour le traitement et/ou la prevention de l’hyperlipidemie, procedes de production et utilisation de cette composition |
EP05817628.0A EP1829519B1 (en) | 2004-12-10 | 2005-12-05 | A pharmaceutical composition for the treatment and/or prevention of hyperlipidemia, processes for producing the same and the use thereof |
US11/721,245 US8747913B2 (en) | 2004-12-10 | 2005-12-05 | Herbal extract pharmaceutical composition and method for treating and/or preventing of hyperlipidemia and processes for producing the same |
AU2005313755A AU2005313755B2 (en) | 2004-12-10 | 2005-12-05 | A pharmaceutical composition for the treatment and/or prevention of hyperlipidemia, processes for producing the same and the use thereof |
CA2589994A CA2589994C (en) | 2004-12-10 | 2005-12-05 | A pharmaceutical composition for the treatment and/or prevention of hyperlipidemia, processes for producing the same and the use thereof |
JP2007544716A JP5184090B2 (ja) | 2004-12-10 | 2005-12-05 | 高脂血症を治療及び/又は予防する医薬組成物、その製法及びその使用 |
HK07114220.6A HK1109561A1 (en) | 2004-12-10 | 2007-12-28 | A pharmaceutical composition for the treatment and/or prevention of hyperlipidemia, processes for producing the same and the use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200410093887XA CN1785284B (zh) | 2004-12-10 | 2004-12-10 | 一种含有何首乌的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1785284A true CN1785284A (zh) | 2006-06-14 |
CN1785284B CN1785284B (zh) | 2012-04-18 |
Family
ID=36577660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200410093887XA Expired - Fee Related CN1785284B (zh) | 2004-12-10 | 2004-12-10 | 一种含有何首乌的药物组合物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US8747913B2 (zh) |
EP (1) | EP1829519B1 (zh) |
JP (1) | JP5184090B2 (zh) |
CN (1) | CN1785284B (zh) |
AU (1) | AU2005313755B2 (zh) |
CA (1) | CA2589994C (zh) |
HK (1) | HK1109561A1 (zh) |
WO (1) | WO2006060951A1 (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1985909B (zh) * | 2007-01-08 | 2010-06-16 | 江苏济川制药有限公司 | 一种用于高脂血症的药物及其生产工艺 |
CN102614271A (zh) * | 2012-04-20 | 2012-08-01 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病性血脂异常的中药 |
CN103239525A (zh) * | 2013-05-23 | 2013-08-14 | 山西省肿瘤研究所 | 一种活血降脂药酒及其制备方法 |
CN106343413A (zh) * | 2016-08-26 | 2017-01-25 | 辽宁好护士生物科技有限公司 | 一种辅助降血糖、降血压、降血脂的保健食品 |
CN106890225A (zh) * | 2017-03-16 | 2017-06-27 | 杨本雷 | 一种降血脂的药物组合物及其制备方法、制剂与应用 |
CN111109518A (zh) * | 2020-02-21 | 2020-05-08 | 黑龙江八一农垦大学 | 一种具有降血脂功效的杂粮饭及其制备方法 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090304822A1 (en) | 2008-06-09 | 2009-12-10 | Chi-Hua Chen | Extract of Polygonum multiflorum Thunb. ex Murray var. hypoleucum and compositions for improving metabolic syndrome |
MY183588A (en) * | 2009-03-30 | 2021-02-27 | Tianjin Tasly Pharmaceutical Co Ltd | New salvianolic acid compound l, preparation method and use thereof |
US20120164242A1 (en) * | 2010-12-27 | 2012-06-28 | Wen-Jen Yu | Novel methods for modulating melanin production |
CN102895349A (zh) * | 2012-10-23 | 2013-01-30 | 李斌 | 一种治疗高血压、高血脂、高血糖的中药茶 |
CN102973720A (zh) * | 2012-12-18 | 2013-03-20 | 兰州博欣医药科技有限公司 | 一种治疗高血脂症的中药复方制剂及其制备方法 |
CN104721083B (zh) * | 2015-02-12 | 2019-02-05 | 上海杏王生态科技有限公司 | 一种纯植物天然活性发胶及其制作方法 |
CN104757464A (zh) * | 2015-04-30 | 2015-07-08 | 黄馨莹 | 一种山楂片剂的制作方法 |
CN106190718A (zh) * | 2016-07-05 | 2016-12-07 | 袁新 | 一种地冬首乌酒 |
CN107773679A (zh) * | 2016-08-25 | 2018-03-09 | 沈阳药科大学 | 一种辅助降血脂、辅助溶解血栓的组合物及其制备工艺 |
CN107574198B (zh) * | 2017-08-18 | 2021-06-08 | 华南理工大学 | 一种采用醇沉分级制备螺旋糊精包结络合载体的方法 |
CN112007119B (zh) * | 2020-10-14 | 2022-06-28 | 上海中医药大学附属岳阳中西医结合医院 | 一种治疗颈动脉硬化的中药组合物及其应用 |
CN115137770B (zh) * | 2022-07-18 | 2023-11-17 | 劲牌持正堂药业有限公司 | 一种具有降血脂血压功效的中药产品制作方法 |
CN115400189B (zh) * | 2022-08-09 | 2023-12-29 | 济南长庚医药科技有限公司 | 糖脂同调的中药组合物、提取物、制备方法及应用和制剂 |
CN117323378B (zh) * | 2023-11-29 | 2024-02-02 | 云南白药集团中药资源有限公司 | 一种降脂化瘀的中药组合物及其制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58172320A (ja) | 1982-04-02 | 1983-10-11 | Zeria Shinyaku Kogyo Kk | 抗高脂血症剤及びその製造方法 |
JPH05268920A (ja) | 1992-02-13 | 1993-10-19 | Toyo Riken Kk | 健康食品及び健康飲料 |
JP3161882B2 (ja) | 1993-06-03 | 2001-04-25 | 日本ケミカルリサーチ株式会社 | 丹参由来多糖類、その製造法および用途 |
CN1109353A (zh) * | 1994-03-31 | 1995-10-04 | 徐祖德 | 一种降脂、降压胶囊的配方及其制作方法 |
US5958417A (en) * | 1996-10-24 | 1999-09-28 | Hsu; Chau-Shin | Herbal combinations |
KR100327894B1 (ko) | 1999-08-25 | 2002-03-09 | 한영복 | 삼칠근과 단삼의 혼합 추출물을 포함하는 고혈압 치료 및 콜레스테롤 저하 조성물 및 그의 제조 방법 |
CN1276219A (zh) | 2000-05-31 | 2000-12-13 | 安红立 | 主治高血脂症的药物 |
JP3495694B2 (ja) | 2000-10-02 | 2004-02-09 | 救心製薬株式会社 | 薬用人参、西洋人参及び田七人参などからなる生薬及びその抽出物、食品、医薬部外品並びに医薬品 |
CN1111054C (zh) * | 2000-10-26 | 2003-06-11 | 桂林三金药业集团公司 | 一种治疗中风的药物及其生产方法 |
CN1383888A (zh) | 2001-12-31 | 2002-12-11 | 曹长城 | 益心康片及其制备方法 |
EP2078033B1 (en) | 2006-09-29 | 2011-03-09 | Janssen Pharmaceutica NV | Isotopically labeled trapping agent and method for identifying reactive metabolites |
-
2004
- 2004-12-10 CN CN200410093887XA patent/CN1785284B/zh not_active Expired - Fee Related
-
2005
- 2005-12-05 JP JP2007544716A patent/JP5184090B2/ja not_active Expired - Fee Related
- 2005-12-05 EP EP05817628.0A patent/EP1829519B1/en not_active Ceased
- 2005-12-05 AU AU2005313755A patent/AU2005313755B2/en not_active Ceased
- 2005-12-05 CA CA2589994A patent/CA2589994C/en not_active Expired - Fee Related
- 2005-12-05 WO PCT/CN2005/002089 patent/WO2006060951A1/zh active Application Filing
- 2005-12-05 US US11/721,245 patent/US8747913B2/en not_active Expired - Fee Related
-
2007
- 2007-12-28 HK HK07114220.6A patent/HK1109561A1/xx not_active IP Right Cessation
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1985909B (zh) * | 2007-01-08 | 2010-06-16 | 江苏济川制药有限公司 | 一种用于高脂血症的药物及其生产工艺 |
CN102614271A (zh) * | 2012-04-20 | 2012-08-01 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病性血脂异常的中药 |
CN103239525A (zh) * | 2013-05-23 | 2013-08-14 | 山西省肿瘤研究所 | 一种活血降脂药酒及其制备方法 |
CN106343413A (zh) * | 2016-08-26 | 2017-01-25 | 辽宁好护士生物科技有限公司 | 一种辅助降血糖、降血压、降血脂的保健食品 |
CN106890225A (zh) * | 2017-03-16 | 2017-06-27 | 杨本雷 | 一种降血脂的药物组合物及其制备方法、制剂与应用 |
CN111109518A (zh) * | 2020-02-21 | 2020-05-08 | 黑龙江八一农垦大学 | 一种具有降血脂功效的杂粮饭及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
US20090291154A1 (en) | 2009-11-26 |
CN1785284B (zh) | 2012-04-18 |
EP1829519A4 (en) | 2009-05-13 |
CA2589994C (en) | 2012-10-02 |
EP1829519A1 (en) | 2007-09-05 |
AU2005313755B2 (en) | 2008-07-31 |
JP5184090B2 (ja) | 2013-04-17 |
US8747913B2 (en) | 2014-06-10 |
EP1829519B1 (en) | 2013-05-01 |
CA2589994A1 (en) | 2006-06-15 |
WO2006060951A1 (fr) | 2006-06-15 |
JP2008522988A (ja) | 2008-07-03 |
AU2005313755A1 (en) | 2006-06-15 |
HK1109561A1 (en) | 2008-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1785284B (zh) | 一种含有何首乌的药物组合物 | |
CN1047946C (zh) | 老年病制剂 | |
CN101274042A (zh) | 治疗高脂血症的药物组合物及其制备方法 | |
CN101953918B (zh) | 一种治疗心脑血管疾病的中药组合物 | |
CN103655791B (zh) | 一种痰瘀同治的荷丹制剂及其应用 | |
CN101632817A (zh) | 一种治疗乳房肿块的中药组合物 | |
CN102302609A (zh) | 一种改善亚健康的复方中药制剂 | |
CN100341547C (zh) | 一种具有调节血脂作用的药物组合物及其制备方法和用途 | |
CN102362971A (zh) | 一种治疗冠心病中药及其有效化学组分的制备方法和制剂 | |
CN1298362C (zh) | 一种治疗盆腔炎的中药复方制剂及其制备方法 | |
CN1730062A (zh) | 一种健脾补肾、宁心安神的中药组合物及制备方法 | |
CN1055227C (zh) | 一种治疗男性不育症的药物及制备方法 | |
CN100409880C (zh) | 一种治疗高脂血症的蒙药保利尔及其制备方法 | |
CN1883660A (zh) | 降血脂中药及其制备方法 | |
CN111000969A (zh) | 一种治疗单纯性肥胖的药物组合物及制备方法 | |
CN101337057A (zh) | 脂清颗粒及其制备方法 | |
CN104173681B (zh) | 一种治疗去势抵抗性前列腺癌的中草药组合物 | |
CN103263581A (zh) | 用于降血糖的双参胶囊 | |
CN1244340C (zh) | 治疗冠心病、心绞痛的中药制剂及其制作方法 | |
CN102366594A (zh) | 一种用于调节月经的中药 | |
CN100344301C (zh) | 一种治疗白癜风病口服药物及其制造方法 | |
CN104721730A (zh) | 一种复方金蒲胶囊及其制备方法 | |
CN105395793A (zh) | 一种中药组合物用于制备治疗慢性稳定性心绞痛药物中的应用 | |
CN1219542C (zh) | 一种改善衰老症状、延缓老化发生的中药及其颗粒剂的制作方法 | |
CN1131049C (zh) | 一种治疗银屑病的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY PHARM. CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300402, No. 1, Liaohe East Road, Beichen Science Park, Beichen District, Tianjin Patentee after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300402, No. 1, Liaohe East Road, Beichen Science Park, Beichen District, Tianjin Patentee before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120418 Termination date: 20171210 |